'Boston Scientific Gets $42 Million Stent Patent Verdict Reversed' - Bloomberg
https://news.bloomberglaw.com/health-law-and-business/boston-scientific-gets-42-million-stent-patent-verdict-reversed
A court said Boston Scientific doesn't have to pay $42 million for copying a stent design—the judge reversed an earlier decision against them. When companies win legal battles like this, it usually means less money they have to spend, which is something to notice when watching the stock.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.